Intended Audience: All neonatal nurses
NCC Codes: NIC3, NNP4, LRN4, Rx3.25

Objectives: Upon completion, learners will be able to:

Discuss adverse effect profiles of agents (e.g., fentanyl, morphine, midazolam) commonly used (for the treatment of pain and agitation in mechanically-ventilated preterm neonates.
Describe the proposed mechanisms by which analgesics and sedatives may cause adverse neurodevelopmental outcomes in preterm neonates.
Describe the potential role for dexmedetomidine in the treatment of pain and agitation in mechanically-ventilated preterm neonates.

Purpose of this CNE activity: In this session, our presenters provide an in-depth review of agents used to treat pain and agitation in critically ill, mechanically-ventilated preterm neonates. The focus is a discussion of adverse effects particularly long-term effects on neurodevelopmental outcomes. A clinical scenario is used to facilitate discussion about selecting analgesics and sedatives in this vulnerable population.

Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.

Access to the internet and the ANN Online Library
Attend and watch 90% of the session
Complete and submit the evaluation for this CNE activity

Accreditation
The Academy of Neonatal Nursing is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.

Release Date: 9/08/2021
Expiration Date: 9/30/2024

Disclosures:

This CNE activity has been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias.
The content of this CNE activity has been developed by the planning committee and has been reviewed by the Lead Nurse Planner.
The speakers discloses no relevant financial interest or affiliations with any commercial interests.

Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.

Kirsten H. Ohler PharmD, BCPS, BCPPS

Clinical Pharmacy Specialist, NICU, University of Illinois at Chicago College of Pharmacy

Appearances